Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Northrop Grumman Corporation (NOC) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Northrop Grumman CorporationTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Northrop Grumman Corporation vs State Street SPDR S&P Biotech ETF — how do they compare? Northrop Grumman Corporation trades at $512.35 (market cap $74.42B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: Northrop Grumman Corporation pays a 1.79% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Northrop Grumman Corporation nearer its low. Which is the better fit depends on your goals.

NOCXBI
Market Cap
$74.42B
Sector
IndustrialsBroad Market / Factor
52-Week High
$768.02$164.28
52-Week Low
$496.02$85.16
Enterprise Value
$88.65B
Dividend Yield
1.79%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Northrop Grumman Corporation

Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.

Read more on NOC

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI